期刊文献+

心房肌葡萄糖转运体-3的水平对冠心病患者冠脉旁路移植术后新发房颤风险的影响 被引量:2

Impaired myocardium GLUT3 levels associated with the risk of new-onset atrial fibrillation after isolated coronary artery bypass grafting surgery
下载PDF
导出
摘要 目的分析心房组织葡萄糖转运体-3(GLUT3)水平与冠心病患者接受冠状动脉旁路移植(CABG)术后新发房颤(POAF)的相关性,并评估影响GLUT3水平的风险因素。方法前瞻性人选79例窦性心律且接受冠脉搭桥的冠心病患者,其中22例患者出现术后新发房颤。收集患者术前、术中和术后的资料,在术中获取右心耳组织保存备分析。POAF由心电图评定,而且必须有抗心律失常治疗。GLUT3的在心肌组织中的浓度用ELISA方法测定。对可能与GLUT3有关的诸因素进行卡方检验和logistic多因素回归分析,以分析GLUT3与POAF的相关性和影响GLUT3水平的风险因素。结果CLUT3水平在发生术后房颤的患者组中明显较低,与POAF明显相关(P<0.05)。在多元线性回归模型中,低GLUT3水平与糖尿病明显相关(95%CI,8171.804-12402.757;P<0.05)。结论心房肌组织GLUT3水平低的患者存在更多术后新发房颤的风险。心房肌组织能量代谢障碍是导致CABG术后新发房颤的可能机制。 Objective The goal of this study was to analyze the relationship between glucose transporters 3 and new-onset atrial fibrillation (AF) after isolated CABG surgery. Methods Right atrial appendages were obtained from 79 patients who were in normal sinus rhythm and undergoing isolated coronary artery bypass grafting, those who exhibited new-onset POAF ( n = 22 ) or remained in sinus rhythm ( SR ) ( n = 57 ) were prospectively matched based on preoperative, intraoperative, and postoperative characteristics. Postoperative atrial fibrillation was assessed by electrocardiogram and must have required initiation of antiarrhythmic therapy or anticoagulation. Local GLUT3 concentration was quantified by enzyme-linked immunosorbent assay (ELISA) in tissue homogenates. Results GLUT3 levels was significant reduced in POAF patients compared with controls ( P 〈 0.05 ). This selective reduction in GLUT5 was associated with presence of metabolism syndrome (MS) and diabetes mellitus ( DM ) ( P 〈 0.05 ). Conclusions Patients who have low GLUT3 levels are in more risk of new-onset postoperative atrial fibrillation. The myofibrillar energetic impairment may be important in the pathogenesis of AF.
出处 《中国分子心脏病学杂志》 CAS 2009年第3期161-163,共3页 Molecular Cardiology of China
基金 国家科技支撑计划(2006BAI01A09)
关键词 房颤 冠脉旁路移植 心房肌 糖转运体 Arrythmia Atrial myocardium Energy metabolism
  • 相关文献

参考文献10

  • 1Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation. 1996; 94: 390-397.
  • 2Mitchell J. Magee, et al. Atrial Fibrillation After Coronary Artery Bypass Grafting Surgery: Development of a Predictive Risk Algorithm. Ann Thorac Surg,2007, 83: 1707-1712.
  • 3Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA, 1996, 276 : 300-306.
  • 4Bing RJ. The metabolism of the heart. Harvey Lect, 1955,50:27-70.
  • 5Morgan HE, Henderson MJ, Regen DM, Park CR. Regulation of glucose uptake in muscle, Ⅰ: the effects of insulin and anoxia on glucose transport and phosphorylation in the isolated perfused heart of normal rats. J Biol Chem, 1961,236:253-261.
  • 6Michael J. Mihm, Fushun YuCirculation, et al. Impaired Myofibrillar Energetics and Oxidative Injury During Human Atrial Fibrillation. Circulation. 2001;104:174.
  • 7S. R. Ommen, J. A. Odell and M.S. Stanton, Atrial arrhythmias after cardiothoracic surgery. N Engl J Med. 1997. 336:1429-1434.
  • 8Stefan Neubauer, M. D. , F. R. C. P. , The Failing Heart - An Engine Out of Fuel, N Engl J Med, 2007,356:1140-1151.
  • 9N. Ono, H. Hayashi and A. Kawase et al. , Spontaneous atrial fibrillation initiated by triggered activity near the pulmonary veins in aged rats subjected to glycolytic inhibition. Am J Physiol Heart Circ Physiol, 2007, 292 : H639-H648.
  • 10Mayr M, Yusuf S, et al. Combined metabolomic and proteomic analysis of human atrial fibrillation. JACC, 2008,51:585-594.

同被引文献23

  • 1Augustin R. The protein family of glucose transport facilitators: It's not only about glucose after all[J]. IUBMB Life, 2010, 62(5) : 315-333.
  • 2Manolescu AR, Witkowska K, Kinnaird A, et al. Facilitated hexose transporters: new perspectives on form and function [J]. Physiology(Bethesda), 2007, 22(4): 234-240.
  • 3Schwenk RW, Luiken JJ, Bonen A, et al. Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease[J]. Cardiovasc Res, 2008, 79(2): 249-258.
  • 4Macheda ML, Kelly DJ, Best JD, et al. Expression during rat fetal development of GLUT12-a member of the class Ⅲ hexose transporter family[J]. Anat Embryol ( Berl), 2002, 205(5-6): 441-452.
  • 5Huggins CE, Domenighetti AA, Ritchie ME, et al. Functional and metabolic remodelling in GLUT4-deficient hearts confers hyper responsiveness to substrate intervention [J]. J Mol Cell Cardiol, 2008, 44(2) :270-280.
  • 6Kaczmarczyk SJ, Andrikopoulos S, Favaloro J, et al. Threshold effects of glucose transporter 4 (GLUT4) deficiency on cardiac glucose uptake and development of hypertrophy[J]. J Mol Endocrinol, 2003, 31(3): 449-459.
  • 7Ritchie RH, Quinn JM, Cao AH, et al. The antioxidant tempol inhibits cardiac hypertrophy in the insulin resistant GLUT4 deficient mouse in vivo[J]. J Mol Cell Cardiol, 2007, 42(6): 1119-1128.
  • 8Espinoza-Derout J, Wagner M, Salciccioli L, et al. Positive transcription elongation factor b activity in compensatory myocardial hypertrophy is regulated by cardiac lineage protein 1[J]. Circ Res, 2009, 104(12): 1347-1354.
  • 9Bateman RM, Tokunaga C, Kareco T, et al. Myocardial hypoxia-inducible HIF-la, VEGF, and GLUT1 gene expression is associated with microvascular and ICAM 1 heterogeneity during endotoxemia[J]. Am J Physiol Heart Circ Physiol, 2007, 293(1): H448-H456.
  • 10Iwai Kanai E, Hasegawa K, Sawamura T, et al. Activation of lectin like oxidized low density lipoprotein receptor-I induces apoptosis in cultured neonatal rat cardiac myocytes [J]. Circulation, 2001, 11)4(24): 2948-2954.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部